Combination of pomalidomide/dexamethasone in the treatment of relapsed/refractory multiple myeloma in patients with del(17p), t(4 ; 14) and t(14 ; 16) chromosome aberrations (CROSBI ID 645591)
Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija
Podaci o odgovornosti
Katalinic, Darko
engleski
Combination of pomalidomide/dexamethasone in the treatment of relapsed/refractory multiple myeloma in patients with del(17p), t(4 ; 14) and t(14 ; 16) chromosome aberrations
Combination of pomalidomide/dexamethasone in the treatment of relapsed/refractory multiple myeloma in patients with del(17p), t(4 ; 14) and t(14 ; 16) chromosome aberrations
pomalidomide, multiple myeloma
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
100-100.
2017.
nije evidentirano
objavljeno
10.1016/S0959-8049(17)30413-6
Podaci o matičnoj publikaciji
European journal of cancer (1990)
Eggermont, Alexander M.M.
Amsterdam: Elsevier
0959-8049
1879-0852
Podaci o skupu
European Cancer Congress (ECCO 2017)
poster
27.01.2017-30.01.2017
Amsterdam, Nizozemska
Povezanost rada
Dentalna medicina, Kliničke medicinske znanosti, Temeljne medicinske znanosti
